World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
14331
World Ranking
3412
National Ranking
48

Jozef Van Damme publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jozef Van Damme sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 140 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jozef Van Damme D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jozef Van Damme sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Cytokine
  • Gene
  • Immune system

Jozef Van Damme spends much of his time researching Immunology, Chemokine, Cell biology, Chemotaxis and Cytokine. His biological study spans a wide range of topics, including Demyelinating disease, Molecular biology and Interleukin 8. His work deals with themes such as Platelet factor 4, Endocrinology and CXC chemokine receptors, which intersect with Interleukin 8.

His work carried out in the field of Cell biology brings together such families of science as CX3CL1, CXCL2 and Neutrophil extravasation. His study with Chemotaxis involves better knowledge in Receptor. His research investigates the connection between Cytokine and topics such as Inflammation that intersect with issues in Cell migration, Cancer cell and Metastasis.

His most cited work include:

  • Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. (968 citations)
  • Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact (590 citations)
  • The CC chemokine CCL20 and its receptor CCR6. (570 citations)

What are the main themes of his work throughout his whole career to date?

Immunology, Chemokine, Chemotaxis, Cell biology and Molecular biology are his primary areas of study. In his research, Endothelial stem cell is intimately related to Angiogenesis, which falls under the overarching field of Chemokine. His work on Chemotaxis is being expanded to include thematically relevant topics such as Monocyte.

His Cell biology research includes elements of Receptor, CXCL2, CCL13 and CCR1. The various areas that Jozef Van Damme examines in his Molecular biology study include Beta, Biochemistry, Messenger RNA and Gelatinase. His work in CXC chemokine receptors tackles topics such as CXCR3 which are related to areas like CXCL16, CX3CL1 and CXCL11.

He most often published in these fields:

  • Immunology (38.57%)
  • Chemokine (36.43%)
  • Chemotaxis (25.71%)

What were the highlights of his more recent work (between 2009-2017)?

  • Chemokine (36.43%)
  • Immunology (38.57%)
  • Cell biology (22.86%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Chemokine, Immunology, Cell biology, Angiogenesis and Chemotaxis. Jozef Van Damme has researched Chemokine in several fields, including Monocyte chemotaxis and Signal transduction. Many of his studies involve connections with topics such as Blood–brain barrier and Immunology.

The Cell biology study combines topics in areas such as CXCL2, Chemokine receptor, CCR1, Inflammation and Agonist. His Angiogenesis study integrates concerns from other disciplines, such as Platelet factor 4, Platelet and Molecular biology. Jozef Van Damme has included themes like Effector, Innate immune system and Monocyte in his Chemotaxis study.

Between 2009 and 2017, his most popular works were:

  • CXCR3 ligands in disease and therapy. (162 citations)
  • The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer (99 citations)
  • Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. (92 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cytokine
  • Immune system

Jozef Van Damme focuses on Immunology, Chemokine, Cytokine, CXCR3 and Cell biology. His Immunology research is multidisciplinary, incorporating perspectives in Stromal cell and Neovascularization. His Chemotaxis research extends to the thematically linked field of Chemokine.

The concepts of his Cytokine study are interwoven with issues in Endothelial stem cell, Myofibroblast, Pathology, CD31 and Serum amyloid A. His CXCR3 research also works with subjects such as

  • Metastasis which is related to area like CXC chemokine receptors, Angiogenesis, Inflammation and Platelet factor 4,
  • CX3CL1, C-C chemokine receptor type 7 and Chemokine receptor CCR5 most often made with reference to CXCL16. His Cell biology study incorporates themes from CXCL2 and CCR1.

Best Publications

  • Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.

    Emmanuel Le Poul;Cecile Loison;Sofie Struyf;Jean-Yves Springael

  • The CC chemokine CCL20 and its receptor CCR6.

    Evemie Schutyser;Sofie Struyf;Jozef Van Damme

  • Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact

    Philippe Van den Steen;Paul Proost;Anja Wuyts;Jozef Van Damme

  • The role of CXC chemokines and their receptors in cancer

    Jo Vandercappellen;Jozef Van Damme;Sofie Struyf

  • Gelatinase B: a tuner and amplifier of immune functions

    Ghislain Opdenakker;Philippe Van den Steen;Jozef Van Damme

  • The MCP/eotaxin subfamily of CC chemokines.

    Els Van Coillie;Jozef Van Damme;Ghislain Opdenakker

  • Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system.

    Hugo Vankelecom;Peter Carmeliet;Jozef Van Damme;Alfons Billiau

  • CXCR3 ligands in disease and therapy.

    Katrien Van Raemdonck;Philippe Van den Steen;Sandra Liekens;Jozef Van Damme

  • Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.

    Evemie Schutyser;Evemie Schutyser;Ann Richmond;Jozef Van Damme

  • Synergy in cytokine and chemokine networks amplifies the inflammatory response

    Mieke Gouwy;Sofie Struyf;Paul Proost;Jozef Van Damme

  • Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma

    Evemie Schutyser;Sofie Struyf;Paul Proost;Ghislain Opdenakker

  • Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation.

    Paul Proost;Tamara Loos;Anneleen Mortier;Evemie Schutyser

  • Murine CXCR1 Is a Functional Receptor for GCP-2/CXCL6 and Interleukin-8/CXCL8

    Xuedong Fan;Andriani C Patera;Amy Pong-Kennedy;Gregory Deno

  • Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet Factor-4/CXCL4 and Potent Inhibitor of Angiogenesis

    Sofie Struyf;Marie D Burdick;Paul Proost;Jozef Van Damme

  • Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer.

    Ghislain Opdenakker;Jozef Van Damme

  • Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis

    Philippe Van den Steen;Paul Proost;Bernard Grillet;David D Brand

  • GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors

    Klara Gijsbers;Mieke Gouwy;Sofie Struyf;Anja Wuyts

  • Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy

    Ahmed M Abu El-Asrar;Sofie Struyf;Dustan Kangave;Karel Geboes

  • The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer

    Jo Vandercappellen;Jozef Van Damme;Sofie Struyf

  • Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.

    Ahmed M Abu El-Asrar;Sofie Struyf;Dustan Kangave;Saleh S Al-Obeidan

  • Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration

    Mieke Gouwy;Sofie Struyf;Julie Catusse;Paul Proost

Frequent Co-Authors

Ghislain Opdenakker
Ghislain Opdenakker Rega Institute for Medical Research
Sofie Struyf
Sofie Struyf KU Leuven
Paul Proost
Paul Proost KU Leuven
Alfons Billiau
Alfons Billiau Rega Institute for Medical Research
Karel Geboes
Karel Geboes Ghent University Hospital
Philippe E. Van den Steen
Philippe E. Van den Steen Rega Institute for Medical Research
Marc Parmentier
Marc Parmentier Université Libre de Bruxelles
Erik De Clercq
Erik De Clercq Rega Institute for Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology opens up diverse career opportunities in healthcare and research. For those interested in nursing, transitioning to specialized roles is a popular pathway. Programs like acute care nurse practitioner programs help registered nurses advance their skills to manage critically ill patients, blending immunology knowledge with clinical expertise.

For aspiring family nurse practitioners, accelerated FNP program options offer a streamlined way to enter this vital role faster. These programs often integrate immunology principles, enhancing the ability to care for patients with immune-related conditions.

Those starting without a nursing background can benefit from 12-month accelerated nursing programs online for non nurses. These programs quickly prepare students for nursing roles and serve as a stepping stone toward advanced immunology-focused careers.

Additionally, exploring the easiest ABSN programs to get into can be an effective strategy for gaining foundational nursing credentials, especially for those eager to combine immunology expertise with clinical practice in a shorter timeframe.

Best Scientists Citing Jozef Van Damme

Trending Scientists